The Niche’s recommended Weekly Reads on stem cell research and regenerative medicine.
Is 2022 going to be any better than 2020 or 2021 when it comes to things in general or for biomedical science? Related to the pandemic? It’s too soon to say but if I had to guess right now I’d venture an optimistic view that overall it’s going to be somewhat better by the end […]
Weekly science reads: senescence, alt CRISPR, sickle cell update Read More »
Happy New Year and get ready for another 364 more days of stem cell excitement and craziness in 2022. In the next day or two I’ll post my predictions for this new year. Recommended reads EO Wilson obit by Carl Zimmer in NYT. Who’s the next EO Wilson or someone like him with such big impact these
Weekly stem cell reads: COVID kidney, FDA letter, H3.3, EO Wilson Read More »
Part of being a grad student is dealing with technologies related to your projects and their limitations. Sometimes I feel old when I remember the way we used to have to do things in the lab. As a grad student, I manually poured, ran, and read giant sequencing gels. Back then, gene synthesis of a
Weekly reads: grad student life, cell barcoding, diabetes trial, more Read More »
What are your favorite cells? The stem variety? T-cells? I have a hard time choosing just one favorite. The first news item I feature talks new imaging methods to see deep inside any cells. Have a favorite organelle? The secret lives of cells — as never seen before, Nature. This news item covers newer imaging techniques
Recommended reads: secrets of cells, T-cells, CRISPR Read More »
The other day I was talking with some folks about stem cell policy on Zoom, which was great, but one phrase from them jumped out at me and gave me a laugh. “Joe Rogan is the Gwyneth Paltrow for bros.” It also just rings true to me. Some readers of The Niche may remember that
Weekly reads: Joe Rogan, stem cell, diet, clinics, more Read More »
Any day now we should get the verdict from the judge in the big stem cell clinic case here in California against Cell Surgical Network, et al. It seems that the FDA is waiting on this verdict before taking some major actions. If the judge rules against the agency it could throw the area into
Weekly stem cell reads: pending FDA verdict, blood vessels, RA Read More »
The stem cell field lost a great scientist and friend this week with the passing of Meri Firpo from metastatic breast cancer. I’m going to post a tribute to Meri from several of us sometime this coming week. I’m in a bit of a somber mood but still trying to write, read, and do all
Weekly stem cell reads: COVID, tail regeneration, aging Read More »
I’ve been busy recently focusing more on grant and paper writing than reading papers on stem cells, but my piece on trying to de-extinct mammoths via cloning-like methods drew strong opinions on both sides. Recent news and resources on stem cells We’re still awaiting a verdict in the big California federal court case where the FDA is
Weekly reads: news, legos for stem cells, FDA, cancer, more Read More »
I’m taking a short break today from working on a big grant to put out this weekly reads post including on Sox transcription factors, cord blood paper controversy, and other interesting papers such as one on CTCF and chromatin domains after mitosis that really struck me. I can actually see blue sky today here in
Weekly reads: CTCF, Sox transcription factors, Clinic fires back, more Read More »
This blog is called The Niche so publications on the stem cell niche often catch my eye even if that’s not something my own lab directly works on much. So today’s recommended reads will start with two papers on the stem cell niche. The first one focused on the niche gone wrong. The stem cell
Recommend reads: stem cell niche, Georgia & FTC on clinics, more Read More »